SynthesisFrontiers in oncology2025
Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.
Bin Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.